Clinical Trial Update: A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for NNC0638-0355 in people with overweight or obesity; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• NNC0638-0355

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Phase 1 | Status: ACTIVE_NOT_RECRUITING